Leco Supports West Coast Metabolomics Center

LCGC Europe eNews

LCGC Europe eNews-03-01-2013, Volume 0, Issue 0

Leco (Michigan, USA) will support the new West Coast Metabolomics Center, based at the University of California, Davis, Genome Center (California, USA).

Leco (Michigan, USA) will support the new West Coast Metabolomics Center, based at the University of California, Davis, Genome Center (California, USA). The center was opened on 8th October 2012, with funding of $9.3 million from the National Institute of Health and Disease.

Directed by Oliver Fiehn, Professor of Molecular and Cellular Biology at UC Davis, the center aims to advance research into understanding and developing treatments for diseases including diabetes, cancer and atherosclerosis using metabolomics. Metabolism differs from person to person and different dosage levels for drugs are required. As part of this support, Leco will provide access to liquid chromatography-high resolution time-of-flight mass spectrometry (LC–HR–TOF) instrumentation.

“This partnership demonstrates LECO’s renewed commitment to the advancement of metabolomics,” said Dr. Jeff Patrick, Director of Marketed Technology, LECO Separation Science. Patrick added that Leco were honoured that Dr. Fiehn and his team chose Leco instrumentation for the West Coast Metabolomics Center and his company was excited about the implications their research will have on the treatment of certain diseases.

For more information, please visit:

www.leco.com